Key Insights

Highlights

Success Rate

95% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.4%

2 terminated out of 59 trials

Success Rate

95.0%

+8.4% vs benchmark

Late-Stage Pipeline

14%

8 trials in Phase 3/4

Results Transparency

24%

9 of 38 completed with results

Key Signals

9 with results95% success

Data Visualizations

Phase Distribution

30Total
Not Applicable (17)
P 1 (3)
P 2 (2)
P 3 (5)
P 4 (3)

Trial Status

Completed38
Recruiting7
Not Yet Recruiting5
Enrolling By Invitation3
Terminated2
Unknown2

Trial Success Rate

95.0%

Benchmark: 86.6%

Based on 38 completed trials

Clinical Trials (59)

Showing 20 of 20 trials
NCT07746037Not ApplicableNot Yet RecruitingPrimary

Assessment of Dietary Balance in Home-Dwelling Patients With Stage 4 and 5 Chronic Kidney Disease Using URIKI (IKI), a Connected Urine Test Strip and In Vitro Diagnostic Medical Device

NCT07391904Not ApplicableEnrolling By InvitationPrimary

Patient-centered Precision Medicine Lab Result Communication for Older Adults

NCT05106387RecruitingPrimary

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

NCT06383390Phase 3Active Not Recruiting

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

NCT07701382Not ApplicableNot Yet RecruitingPrimary

Remote vs In-Person Prehabilitation for Kidney Transplant Candidates

NCT07660757Completed

Epidemiological Cluster Evaluation in Patients Admitted to Internal Medicine, With at Least One of the Following Diagnoses: Heart Failure, COPD, Renal Failure. The FADOI IN-CluDiMI Study

NCT07662889Not ApplicableEnrolling By Invitation

Comparing Hemodiafiltration to Conventional Hemodialysis: Effects on Clinical and Biochemical Parameters

NCT07572890Phase 1Recruiting

Adia Med of Winter Park LLC Chronic Kidney Disease Research Study

NCT04064827Phase 3TerminatedPrimary

A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

NCT01530958Not ApplicableCompletedPrimary

Kidney Awareness Registry and Education

NCT05092347Phase 1Active Not RecruitingPrimary

A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)

NCT07585695Not Yet RecruitingPrimary

Coronary Artery Disease Screening in Patients With Chronic Kidney Disease

NCT07493642Not ApplicableRecruitingPrimary

Multimedia Health Education on Physical Fitness and Physical Activity for Patients With Chronic Kidney Disease

NCT07381101CompletedPrimary

Trazodone and the Risk of Serious Adverse Events

NCT06202235RecruitingPrimary

Multifrequency MRE in Evaluation of Chronic Kidney Diseases

NCT07399795CompletedPrimary

Citalopram and the Risk of Serious Adverse Events

NCT07387120CompletedPrimary

Sertraline and the Risk of Serious Adverse Events

NCT07382960Completed

Pramipexole and the Risk of Serious Adverse Events

NCT07274241CompletedPrimary

Escitalopram and the Risk of Serious Adverse Events

NCT07274228CompletedPrimary

Tamsulosin and the Risk of Serious Adverse Events

Scroll to load more

Research Network

Activity Timeline